Healthcare provider profile · identity verified

Arrel Silva Olano, MD

Internal Medicine · WASHINGTON, DC · NPI 1053446112

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	575	192
Amlodipine Besylate	Amlodipine Besylate	489	165
Losartan Potassium	Losartan Potassium	263	90
Albuterol Sulfate Hfa	Albuterol Sulfate	232	68
Gabapentin	Gabapentin	211	63
Fluticasone Propionate	Fluticasone Propionate	180	68
Hydrochlorothiazide	Hydrochlorothiazide	180	62
Metformin Hcl	Metformin Hcl	145	61
Metoprolol Succinate	Metoprolol Succinate	141	44
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	138	23
Jardiance	Empagliflozin	132	54
Pantoprazole Sodium	Pantoprazole Sodium	132	42
Lisinopril	Lisinopril	119	46
Carvedilol	Carvedilol	113	37
Eliquis	Apixaban	112	38
Allopurinol	Allopurinol	110	31
Furosemide	Furosemide	110	41
Omeprazole	Omeprazole	108	34
Ozempic	Semaglutide	99	17
Tramadol Hcl	Tramadol Hcl	85	22
Tamsulosin Hcl	Tamsulosin Hcl	82	25
Tizanidine Hcl	Tizanidine Hcl	82	23
Rosuvastatin Calcium	Rosuvastatin Calcium	71	33
Levothyroxine Sodium	Levothyroxine Sodium	70	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	68	26
Diclofenac Sodium	Diclofenac Sodium	67	30
Duloxetine Hcl	Duloxetine Hcl	63	17
Pravastatin Sodium	Pravastatin Sodium	62	20
Hydralazine Hcl	Hydralazine Hcl	54	24
Simvastatin	Simvastatin	50	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	47	17
Humalog Kwikpen U-100	Insulin Lispro	47	15
Mirtazapine	Mirtazapine	47	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	17
Potassium Chloride	Potassium Chloride	45	suppressed
Trulicity	Dulaglutide	41	12
Metformin Hcl Er	Metformin Hcl	40	11
Spironolactone	Spironolactone	39	19
Meloxicam	Meloxicam	38	17
Spiriva Respimat	Tiotropium Bromide	38	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	37	suppressed
Pregabalin	Pregabalin	37	11
Ezetimibe	Ezetimibe	36	15
Januvia	Sitagliptin Phosphate	36	16
Trazodone Hcl	Trazodone Hcl	36	14
Acetaminophen-Codeine	Acetaminophen With Codeine	35	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	35	16
Prednisone	Prednisone	35	suppressed
Alendronate Sodium	Alendronate Sodium	34	suppressed
Chlorthalidone	Chlorthalidone	34	14
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Clopidogrel	Clopidogrel Bisulfate	33	18
Sertraline Hcl	Sertraline Hcl	32	11
Hydroxyzine Hcl	Hydroxyzine Hcl	31	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	30	15
Donepezil Hcl	Donepezil Hcl	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	11
Levetiracetam	Levetiracetam	29	suppressed
Famotidine	Famotidine	28	15
Escitalopram Oxalate	Escitalopram Oxalate	27	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Alprazolam	Alprazolam	26	suppressed
Finasteride	Finasteride	26	suppressed
Montelukast Sodium	Montelukast Sodium	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Levemir Flexpen	Insulin Detemir	23	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	20	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	20	suppressed
Baclofen	Baclofen	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Lactulose	Lactulose	19	suppressed
Latanoprost	Latanoprost	19	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Celecoxib	Celecoxib	18	suppressed
Glipizide	Glipizide	18	suppressed
Lidocaine	Lidocaine	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Nitroglycerin	Nitroglycerin	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Desloratadine	Desloratadine	17	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	17	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Creon	Lipase/Protease/Amylase	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Clonazepam	Clonazepam	15	suppressed
Clotrimazole	Clotrimazole	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Glimepiride	Glimepiride	13	suppressed
Linzess	Linaclotide	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Synjardy	Empagliflozin/Metformin Hcl	13	suppressed
Torsemide	Torsemide	13	suppressed
Ambien	Zolpidem Tartrate	12	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	12	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Irbesartan	Irbesartan	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Trijardy Xr	Empaglifloz/Linaglip/Metformin	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error